Day: February 19, 2026

EDMONTON, Alberta, Feb. 19, 2026 (GLOBE NEWSWIRE) — SNDL Inc. (NASDAQ: SNDL, CSE: SNDL) (“SNDL“) announced today that it will release its fourth quarter and full year 2025 financial results for the period ended December 31, 2025, before markets open on Thursday, March 12, 2026. Following the release of its fourth quarter results, SNDL will host a conference call and webcast at 10:00 a.m. EDT (8:00 a.m. MDT) on March 12, 2026. WEBCAST ACCESS To access the live webcast of the call, please visit the following link: https://edge.media-server.com/mmc/p/aps8jm4e ABOUT SNDL INC.  SNDL Inc. (NASDAQ: SNDL, CSE: SNDL), through its wholly owned subsidiaries, is one of the largest vertically integrated cannabis companies and the largest private-sector liquor and cannabis retailer in Canada, with retail banners that include Ace...

San Antonio, TX, Feb. 19, 2026 (GLOBE NEWSWIRE) — U.S. Global Investors, Inc. (Nasdaq: GROW) will host a webcast on Monday, February 23, at 7:30 a.m. Central time to discuss the company’s results for the second quarter of fiscal year 2026. ­Financial data for the fiscal year will be released prior to the webcast. Frank Holmes, Chief Executive Officer and Chief Investment Officer; Lisa Callicotte, Chief Financial Officer; and Holly Schoenfeldt, Director of Marketing, will participate in the webcast. Click here to register for the webcast. About U.S. Global Investors, Inc. The story of U.S. Global Investors goes back more than 50 years when it began as an investment club. Today, U.S. Global Investors, Inc. (www.usfunds.com) is a registered investment adviser that focuses on niche markets around the world. Headquartered in San Antonio,...

Phase 1b expansion cohort data evaluating 2000mg of ficerafusp alfa every other week in combination with pembrolizumab in 1L HPV-negative R/M HNSCC patients demonstrate rapid, deep and durable responses with generally well-tolerated safety profile  Company plans to develop a loading and every-three-week maintenance regimen for ficerafusp alfa, pending regulatory alignment Company to host conference call and webcast on Friday, February 20, 2026 at 8:30 a.m. ET BOSTON, Feb. 19, 2026 (GLOBE NEWSWIRE) — Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, today presented preliminary safety and efficacy data from an exploratory Phase 1b expansion cohort evaluating 2000mg of ficerafusp alfa every other week (Q2W)...

SAN FRANCISCO, Feb. 19, 2026 (GLOBE NEWSWIRE) — Olema Pharmaceuticals, Inc. (“Olema”, or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and beyond, today announced that Sean P. Bohen, M.D., Ph.D., President and Chief Executive Officer, will present at the TD Cowen 46th Annual Health Care Conference on Tuesday, March 3, 2026 at 2:30 p.m. ET. A live webcast and recording of this presentation will be available, as permitted by the event host, in the Events and Presentations section of Olema’s investor relations website at ir.olema.com. About Olema OncologyOlema Oncology is a clinical-stage biopharmaceutical company committed to transforming the standard of care and improving outcomes for patients living...

EMERYVILLE, Calif., Feb. 19, 2026 (GLOBE NEWSWIRE) — BioAge Labs, Inc. (NASDAQ: BIOA) (“BioAge”, “the Company”), a clinical-stage biotechnology company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging, today announced that the Company will present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference taking place February 25-26, 2026. Kristen Fortney, PhD, CEO and co-founder, is scheduled to participate in a fireside chat on Thursday, February 26 from 10:40 AM to 11:05 AM ET. Fortney and Dov Goldstein, MD, CFO, will participate in one-on-one meetings. To access the live webcast of the presentation, register here. Replays of the webcast will be available in the investor section of the Company’s website at https://ir.bioagelabs.com/,...

BETHESDA, Md., Feb. 19, 2026 (GLOBE NEWSWIRE) — Host Hotels & Resorts, Inc. (NASDAQ: HST) (the “Company”), the nation’s largest lodging real estate investment trust, today provided an updated investor presentation for fourth quarter 2025 results. The investor presentation can be found on the Investor Relations section on the Company’s website at https://www.hosthotels.com/#key-investors-materials. ABOUT HOST HOTELS & RESORTS Host Hotels & Resorts, Inc. is an S&P 500 company and is the largest lodging real estate investment trust and one of the largest owners of luxury and upper-upscale hotels. The Company currently owns 71 properties in the United States and five properties internationally totaling approximately 41,700 rooms. The Company also holds non-controlling interests in seven domestic joint ventures.SOURAV...

SOUTH BEND, Ind., Feb. 19, 2026 (GLOBE NEWSWIRE) — Strawberry Fields REIT, Inc. (NYSE AMERICAN:STRW) (the “Company”) reported today its operating results for the year ended December 31, 2025. Select 2025 Financial Highlights100% of contractual rents collected. On January 1, 2025, the Company entered into a new master lease for 10 Kentucky properties formally part of the Landmark Master Lease. Base rent is $23.3 million a year and is subject to an increase based on CPI with a minimum increase of 2.50%. The initial lease term is 10 years with four 5-year extension options. Also, as part of the negotiation of the new Kentucky Master Lease, the Company entered into a 5 year note payable with the parent of the Landmark tenant for $50.9 million dollars, included in Note Payable in the accompanying condensed consolidated balance sheets. On...

CALGARY, Alberta, Feb. 19, 2026 (GLOBE NEWSWIRE) — Gran Tierra Energy Inc. (“Gran Tierra” or the “Company”) (NYSE American:GTE) (TSX:GTE) (LSE:GTE) is pleased to announce that it has entered into a purchase and sale agreement to sell its remaining working interest in the Simonette asset for total cash consideration of C$62.5 million and will have an effective date of January 1, 2026. The transaction completes Gran Tierra’s exit from Simonette and will deliver cash proceeds that will be directed toward deleveraging the balance sheet. This divestiture reflects the Company’s continued focus on portfolio optimization, free cash flow, disciplined capital allocation, and strengthening its financial position by reallocating capital toward higher-return opportunities across its core operating areas. Closing of the transaction is expected...

St. Petersburg, Fla., Feb. 19, 2026 (GLOBE NEWSWIRE) — On February 19, 2026, the Raymond James Financial, Inc. (NYSE: RJF) Board of Directors declared a quarterly cash dividend on shares of its common stock of $0.54 per share, payable April 15, 2026 to shareholders of record on April 1, 2026. About Raymond James Financial, Inc. Raymond James Financial, Inc. (NYSE: RJF) is a leading diversified financial services company providing private client group, capital markets, asset management, banking and other services to individuals, corporations and municipalities. Total client assets are $1.80 trillion. Public since 1983, the firm is listed on the New York Stock Exchange under the symbol RJF. Additional information is available at www.raymondjames.com. Forward-Looking Statements Certain statements made in this press release may constitute...

HOUSTON, Feb. 19, 2026 (GLOBE NEWSWIRE) — Kayne Anderson Energy Infrastructure Fund, Inc. (the “Company”) (NYSE: KYN) today announced the renewal of its unsecured revolving credit facility (the “Credit Facility”). The renewed Credit Facility maintains the Company’s existing $175 million commitment and extends the maturity to February 18, 2027, replacing the prior facility that was scheduled to mature on February 19, 2026. Borrowings under the renewed Credit Facility bear interest at SOFR plus a spread ranging from 1.30% to 2.15%, based on the Company’s asset coverage ratios. Based on current asset coverage levels, borrowings bear interest at SOFR plus 1.30%. The Company also pays a commitment fee of 0.20% per annum on any unused portion of the Credit Facility. As of February 19, 2026, the Company had $58 million outstanding under...